| Literature DB >> 29181027 |
Gabriela Islas1, Israel S Ibarra1, Prisciliano Hernandez2, Jose M Miranda3, Alberto Cepeda3.
Abstract
To achieve analytical success, it is necessary to develop thorough clean-up procedures to extract analytes from the matrix. Dispersive solid phase extraction (DSPE) has been used as a pretreatment technique for the analysis of several compounds. This technique is based on the dispersion of a solid sorbent in liquid samples in the extraction isolation and clean-up of different analytes from complex matrices. DSPE has found a wide range of applications in several fields, and it is considered to be a selective, robust, and versatile technique. The applications of dispersive techniques in the analysis of veterinary drugs in different matrices involve magnetic sorbents, molecularly imprinted polymers, carbon-based nanomaterials, and the Quick, Easy, Cheap, Effective, Rugged, and Safe (QuEChERS) method. Techniques based on DSPE permit minimization of additional steps such as precipitation, centrifugation, and filtration, which decreases the manipulation of the sample. In this review, we describe the main procedures used for synthesis, characterization, and application of this pretreatment technique and how it has been applied to food analysis.Entities:
Year: 2017 PMID: 29181027 PMCID: PMC5664330 DOI: 10.1155/2017/8215271
Source DB: PubMed Journal: Int J Anal Chem ISSN: 1687-8760 Impact factor: 1.885
Figure 1Scheme of dispersion methodology by dispersive solid phase extraction.
Figure 2Scheme of dispersion solid phase extraction applied for different techniques.
Molecularly imprinted polymers applied to dispersive techniques in the analysis of veterinary drugs.
| Analyte | Matrix | Polymerization or synthesis method | Mode | Technique | Limit of detection | Recovery | Reference |
|---|---|---|---|---|---|---|---|
| BAs | Water, honey, and milk | Copolymerization ionic liquid monolith/AMII with DB/initiator AIBN/porogen DMF/removing the residue with MeOH | SCSE-AMIIDB | HPLC-DAD | 0.020–0.072 | 70.2–117.6% | [ |
|
| |||||||
| CLB | Biological fluid (bovine) | Coprecipitation (FeCl2-FeCl3)/monomer MAA, template tert-butylamine, 2-chloroaniline, cross-linker EGDMA, initiator AIBM, with porogen MeOH:acetic acid | MHIM-DSPE | HPLC-UV | 0.085 ng mL−1 | 91.4–105.3% | [ |
|
| |||||||
| FQs | Milk | Copolymerization of active vinyl groups present on the nanomagnetic POSS (Fe3O4@MI-POSS)/monomer MAA, template enrofloxacin, cross-linker octavinyl POSS | MI-MSPE | HPLC-UV | 1.76 and 12.42 ng mL−1 | 75.6–108.9% | [ |
|
| |||||||
| FQs | Milk | Fe3O4-ethylene glycol, ethylene diamine, ammonium acetate | MI-MSPE | HPLC-UV | 1.8–3.2 ng g−1 | 94.0–124.4% | [ |
|
| |||||||
| QNs | Chicken tissue | Polymerization with 2-HEMA/template OFL and hydrophilic monomer, cross-linker EGDMA with porogen MeOH | MIP-MSPD | HPLC-DAD | 0.008–0.009 | 82.7–102.0% | [ |
|
| |||||||
| SAs | Chicken breast muscle | CS-NR-Mag-MIP/ultrasound-suspension polymerization with GMA, MMA, DVB/Fe3O4 magnetite/template SAs@TEPA | DMSPE | UFLC-MS/MS | 0.0043–0.033 ng g−1 | 85.0–112.2% | [ |
|
| |||||||
| SAs | Duck and chicken tissues | Copolymerization Fe3O4@SiO2/monomer MAA, cross-linker EGDMA, initiator AIBM, template SMZ | MI-MSPE | HPLC-UV | 2.0 mg kg−1 | 63.3–76.5% (duck) | [ |
|
| |||||||
| TCs | Egg and chicken tissue | MeOH:acetic acid | MMIPS | LC-MS/MS | 0.2 ng g−1 | 72.8–96.5% | [ |
|
| |||||||
|
| Pig tissues (muscle, liver) | Bulk polymerization (monomer MAA/cross-linker EGDMA/initiator AIBM/with porogen MeOH and template RAC) | MISDSPE | HPLC-UV | 0.2–0.9 | 83.8–115.2% | [ |
|
| |||||||
|
| Pork and pig liver | Coprecipitation (FeCl3-FeSO4) in ammonia/monomer AM, cross-linker TRIM, template RAC, initiator AIBM, with porogen MeOH | MMIPS | HPLC-FL | 0.52–1.04 ng mL−1 | 80.4–90.0% | [ |
TCs: tetracyclines; CLB: clenbuterol; FQs: fluoroquinolones; QNs: quinolones; SAs: sulfonamides; RAC: ractopamine; BAs: benzimidazole anthelmintics; MAA: methacrylic acid; EGDMA: ethylene glycol dimethacrylate; DB: divinylbenzene; AIBM: azo(bis)-isobutyronitrile; DMF: N,N-dimethylformamide; OFL: ofloxacin; 2-HEMA: 2-hydroxyethyl methacrylate; AMII: 1-allyl-3-methylimidazolium bis[(trifluoro-methyl)sulfonyl] imide; MeOH: methanol; AM: acrylamide; TRIM: trimethylolpropane trimethacrylate; CIP: ciprofloxacin; OTC: oxytetracycline; GMA: glycidyl methacrylate; DVB: divinylbenzene; TEPA: tetraethylenepentamine; POSS: polyhedral oligomeric silsesquioxanes; SMZ: sulfamethazine; CS-NR-Mag-MIP: core-shell nanoring amino-functionalized superparamagnetic molecularly imprinted polymer; MMIPS: magnetic molecularly imprinted polymer; MISDSPE: molecularly imprinted polymer-dispersive SPE; MHIM: magnetic hybrid imprinted polymers; DMSPE: dispersive micro-solid-phase extraction; MI-MSPE; molecularly imprinted magnetic solid-phase extraction; SCSE: stir cake sorptive extraction; MSPD: matrix solid-phase dispersion.
Magnetic sorbents applied to dispersive techniques in the analysis of veterinary drugs.
| Analyte | Matrix | Magnetic material coating | Eluent | Mode | Technique | Limit of detection | Recovery | Reference |
|---|---|---|---|---|---|---|---|---|
| Bisphenol A | Milk | Magnetic NPs-nylon 6 composite | MeOH | DMSPE | HPLC-UV | 3.05 | 86.0–99.0% | [ |
|
| ||||||||
| BZD | Swine tissue | Distillation-precipitation polymerization/Fe3O4/SiO2/poly(MAA-co-EGDMA) composite (mixture of MPS-modified, Fe3O4/SiO2, MAA, EGDMA, AIBN) | CAN-TFA | MSPE | CZE-UV | 1.05–10.42 ng g−1 (muscle) | 81.1–105.4% | [ |
|
| ||||||||
| Estrogens | Meat (pork) | Magnetic nanoparticles (MNPs)/synthesis of CTAB-coated Fe3O4@caprylic acid NPs | MeOH | DMSPE | HPLC-DAD | 0.02–0.03 ng mL−1 | 93.3–106.7% | [ |
|
| ||||||||
| NSAIDs | Milk, human urine, and water | Magnetic ethylenediamine-functionalized graphene oxide nanocomposite | MeOH | UAMDSPME | HPLC-DAD | 0.03–0.1 ng mL−1 | 86.4–109.9% | [ |
|
| ||||||||
| NSAIDs | Urinary | 2-Aminobenzothiazole was polymerized on Fe3O4, graphene oxide/Fe3O4, graphene/Fe3O4 | Methanol/acetonitrile | MSPE | HPLC-DAD | 0.07–0.3 | 85.5–90.5% | [ |
|
| ||||||||
| QNs | Milk | Emulsion polymerization magnetic octyl-phenyl silica (TMOS and PTMS-C8 at different molar ratios) | MeOH-NaOH | MSPE | CE-UV | 9.0–12.0 | 74.0–98.0% | [ |
|
| ||||||||
| SAs | Milk | Distillation-precipitation polymerization/Fe3O4/SiO2/poly(MAA-co-EGDMA) composite (mixture of MPS-modified, Fe3O4/SiO2, MAA, EGDMA, AIBN, ACN) | Acetone-5% ammonia | MSPE | LC-MS/MS | 0.5–49.5 ng L−1 | 87.6–115.6% | [ |
|
| ||||||||
| SAs | Milk | Emulsion polymerization magnetic phenyl silica (PTMS and TMOS at different molar ratios) | MeOH-NaOH | MSPE | HPLC-DAD | 7.0–14.0 | 81.8–114.9%, | [ |
|
| ||||||||
| SAs | Milk | Presynthesized Fe3O4 nanoparticles (NPs) onto HCP/(HCP/Fe3O4) | ACN | MSPE | HPLC-DAD | 2.0–2.5 ng mL−1 | 84.0–105.0% | [ |
|
| ||||||||
| TCs | Milk | Emulsion polymerization magnetic phenyl silica (PTMS and TMOS at different molar ratios) | MeOH-acetic acid | MSPE | CE-DAD | 2.0–9.0 | 94.2–99.8% | [ |
ACN: acetonitrile; AIBM: azo(bis)-isobutyronitrile; BZD: benzimidazole; CE: capillary electrophoresis; C8: octyltrimethoxysilane; CTAB: cetyltrimethylammonium bromide; DAD: diode array detector; DMSPE: dispersive micro-solid phase extraction; EGDMA: ethylene glycol dimethacrylate; HCP: hypercross-linked polystyrene; HPLC: high performance liquid chromatography; MAA; methacrylic acid; MeOH: methanol; MSPE: magnetic solid-phase extraction; NaOH: hydroxide sodium: NSAIDs: nonsteroidal anti-inflammatory drugs; QNs: quinolones; PTMS: phenyltrimethylsilane; SAs: sulfonamides; TCs: tetracyclines; TFA: trifluoroacetic acid; TMOS: tetramethyl orthosilicate; UAMDSPME: ultrasound-assisted magnetic dispersive solid-phase microextraction; UV: ultraviolet visible.
Applications of dispersive techniques in the analysis of veterinary drugs.
| Analyte | Matrix | Functional group | Eluent | Mode | Technique | Limit of detection | Recovery | Reference |
|---|---|---|---|---|---|---|---|---|
| BAs | Milk | C18 | ACN | DSPE | UHPLC-MS/MS | 0.14–1.9 | 58.0–116.0% | [ |
|
| ||||||||
| Bisphenol A | Bovine milk | C18 | ACN | DSPE | LC-MS/MS | 0.15–0.28 | 95.0–106.0% | [ |
|
| ||||||||
| NIIMs | Aquaculture tissue | C18 and Z-Sep | ACN | DSPE | UHPLC-MS/MS | 0.07–1.0 | 77.0–88.0% | [ |
|
| ||||||||
| NIIMs, NFs, and CAP | Chicken muscle and egg | C18 | Ethyl acetate | DSPE | UHPLC-MS/MS | 0.03–0.16 | 86.4–116.7% | [ |
|
| ||||||||
| QNs and TC | Chicken and pork muscles | Coprecipitation (Fe3O4) with terbium and europium ion coated magnetic nanocomposite | EDTA (TC) Mg(NO3)2 pH 9.8 (QN) | DSPE | UHPLC-FL | 0.8–4.0 | 61.5–102.6% | [ |
|
| ||||||||
| QNs | Swine muscle | Primary and secondary amine/ACN extract | MeOH-NaH2PO4 pH 2.5 | DMSPE | HPLC-DAD | 7.5–26.3 | 95.5–111.0% | [ |
|
| ||||||||
| QNs and | Raw cow milk | Primary and secondary amine/extraction solvent mixture of acetonitrile/methanol/McIlvaine buffer pH 6 | — | UAE/DSPE | UHPLC-MS/MS | 0.2–0.6 ng g−1 (QNs) | 96.0–104.5% | [ |
|
| ||||||||
| SAs | Chicken muscle | C18/ACN extract | ACN | DSPE | LC-FL | 1.0–5.0 | 90.0–95.0% | [ |
|
| ||||||||
| SAs | Milk | Butylamide silica | MeOH-basified | DSPE | CE-DAD | 0.05 mg L−1 | 73.0–85.0% | [ |
|
| ||||||||
| TCs | Water and milk | Primary and secondary amine, or carbonyl groups/ACN extract | — | DSPME | HPLC-DAD | 0.7–3.5 ng mL−1 (water) | 97.1–104.1% | [ |
|
| ||||||||
|
| Bovine kidney tissue | C18 | — | DSPE | LC-MS/MS | — | 58.0% | [ |
ACN: acetonitrile; BAs: benzimidazole anthelmintics; CAP: chloramphenicol; C18: octadecyl; DMSPE: dispersive micro-solid-phase extraction; DSPE: dispersive solid-phase extraction; DSPME: dispersive solid-phase microextraction; FL: fluorescence; HPLC: high performance liquid chromatography; LC; liquid chromatography; MeOH: methanol; NIIMs: nitroimidazoles; NFs: nitrofurans; QNs: quinolones; SAs: sulfonamides; TCs: tetracyclines; UAE: ultrasound-assisted extraction; UHPLC: ultra-high performance liquid chromatography.
Carbon-based nanomaterials applied to dispersive techniques in the analysis of veterinary drugs in different matrices.
| Analyte | Matrix | Silica-based functionalized | Eluent | Mode | Technique | Limit of detection | Recovery | Reference |
|---|---|---|---|---|---|---|---|---|
| AT, RT, and MT | Chicken muscle | MWCNT | 5% formic acid in ACN | r-DSPE | UHPLC-MS/MS | 0.15–0.20 | 96.8–104.6% | [ |
|
| ||||||||
| QNs | Water | O-MWCNT prepared by a slight modification | Acetone-MeOH | DSPE | CE-DAD | 28.0–94.0 ng L−1 | 62.3–116% | [ |
|
| ||||||||
| RAL | Ground dried feed | MWCNT | Ethyl acetate | DSPE | UHPLC-ESI-MS/MS | 0.20–0.29 | 95.3–107.2% | [ |
|
| ||||||||
| SAs | Mineral water | MWCNT/magnetic-MWCNT (Magnetic nanoparticles synthesized by means of a solvothermal process, assembled onto CNTs through an “aggregation wrap” mechanism) | MeOH | DSPE | UHPLC-DAD | 32.0 ng L−1 | 61.0–110.0% MWCNT | [ |
|
| ||||||||
| SAs | Pork | MWCNT | ACN/ammonium acetate | DSPE | UHPLC-ESI-MS/MS | 112.0–129.0 | 89.2–117.9% | [ |
|
| ||||||||
| SDZ | Milk and honey | Graphene oxide was synthesized using the modified Hummers method and functionalized with iron oxide nanoparticles via coprecipitation | MeOH/acetic acid | DMSPE | OAMTLS | 0.34 | 95.3–98.3% | [ |
ACN: acetonitrile; AT: amantadine; CE: capillary electrophoresis; CNTs: carbon nanotubes; DAD: diode-array detection; DMSPE: dispersive micro-solid-phase extraction; DSPE: dispersive solid-phase extraction; EDTA: ethylenediaminetetraacetic acid; ESI-MS/MS: electrospray ionization tandem mass spectrometry; Mg(NO3)2: magnesium nitrate; MS: mass spectrometry; MT: memantine; MWCNT: multiwalled carbon nanotubes; OAMTLS: optimized angled mode-mismatched thermal lens spectrometer; O-MWCNT: oxidized multiwalled carbon nanotubes; QNs: quinolones; RAL: resorcylic acid lactones; r-DSPE: reversed-dispersive solid phase extraction; RT: rimantadine; SAs: sulfonamides; SDZ: sulfadiazine; TCs: tetracyclines; UHPLC: ultra-high performance liquid chromatography; UV: ultraviolet detection.
QuEChERS applied to dispersive techniques in the analysis of veterinary drugs in different matrices.
| Analyte | Matrix | Extraction procedure | Clean-up | Technique | Limit of detection | Recovery | Reference |
|---|---|---|---|---|---|---|---|
| BAs | Milk and ovine muscle | 10 g of milk simple + 10.0 mL ACN + 5 g MgSO4:NaCl | DSPE | HPLC-MS/MS | 2.2–2.08 | 108.0–106.0% | [ |
| The mixture was shaken and centrifuged; the supernatant was cleaned by DMSO solution | 771.0–746.0 | 109.0–108.0% | |||||
|
| |||||||
| BZDs | Eggs | 3 g of sample + ACN + 4 g of MgSO4/1 g of NaCl/1.0 mL of ammonium formate solution (10.3 M, pH 7.5) | DSPE PSA/MgSO4 | CE-MS | 3.0–51.0 | 74.0–112.0% | [ |
|
| |||||||
| CAP, TAP, and FF | Milk and honey | 2 g sample + 15.0 mL of 1% HAc + 4 g Na2SO4 + 1 g NaCl shaken and centrifuged. Supernatant with 15 g of C18, 0.35 g of C18 endcapped sorbents and 0.5 g of QuE Z-Sep+ | QuEChERS Z-Sep+/C18 | LC-MS/MS | 0.02−0.045 ng g−1 | 95.8–100.2% (milk) | [ |
| The supernatant was evaporated and reconstituted in 0.5 mL of 10% CAN/water | 95.6–99.3% (honey) | ||||||
|
| |||||||
| Multiresidue | Chicken tissue | Extraction by SPE, supernatant was added 500 mg (NH2 or PSA), shaken, and centrifuged | DSPE/NH2/PSA | LC-MS/MS | 0.27–444.0 | 37.0–89.0% | [ |
|
| |||||||
| Multiresidue | Honey | A modified QuEChERS without addition of PSA followed by evaporation under vacuum was employed + 4 g of MgSO4 and 1 g NaCl, shaken and centrifuged and reconstituted into 1.0 mL of ammonium formate in MeOH/water | QuEChERS | LC-MS/MS | 0.12–0.74 | 90.9–104.8% | [ |
|
| |||||||
| Multiresidue | Muscle tissue | 5 g of sample + 10.0 mL 2% HAc:ACN + 2 g NaCl + 40 g Na2SO4 | QuEChERS/C18 | UHPLC-MS/MS | 0.007–66.715 | 60.0–120.0% | [ |
|
| |||||||
| Multiresidue | Eggs | 10 g of sample + 1% of acetic acid/ACN/0.1 M Na2EDTA solution, with 4 g of MgSO4/1 g sodium acetate | PSA | UHPLC-MS/MS | 2.1–220.8 mg kg−1 | 70.4–94.8% | [ |
|
| |||||||
| Multiresidue | Milk | 10 g of sample + 1% of acetic acid in ACN/0.1 M Na2EDTA solution, with 4 g of MgSO4/1 g of sodium acetate | DSPE/PSA | UHPLC-MS/MS | 1.0–4.0 mg kg−1 | 70.0–110.0% | [ |
|
| |||||||
| Multiresidue | Chicken muscle | 5 g of the sample + water/1% acetic acid/in a solution of ACN:water | PSA | UHPLC-MS/S | 3.0–6.0 | 70.0–120.0% | [ |
|
| |||||||
| Multiresidue | Fish muscle | 5 g of sample + water, in ACN:MeOH solution | — | UHPLC-MS/S | 7.5 | 69.0–125.0% | [ |
|
| |||||||
| Multiresidue | Feedstuffs | 2 g of ground sample + MeOH:ACN | DSPE/PSA | LC-MS/MS | 0.42–5.74 | 56.7–103.0% | [ |
|
| |||||||
| Multiresidues | Bovine muscle | 2 g sample + 10.0 mL of ACN/water, shaken, centrifuged and 10.0 mL of hexane/can. Reconstituted with 0.1% formic acid | Z-Sep/C18 | UHPLC-MS/MS | — | 70.0–120.0% | [ |
|
| |||||||
| Multiresidues | Animal tissues | DSPE: 2 g sample + 10.0 mL of ACN/water was shaken and centrifuged | DSPE-EMR-L | UHPLC-MS/MS | — | 32.0–140.0% (DSPE) | [ |
| EMR-L: 2 g sample + 10.0 mL ACN/5% formic acid was shaken and centrifuged | 4.0–148.0% (EMR-L) | ||||||
|
| |||||||
| NSAIDs | Milk | 5 g of sample + 10.0 mL of 5% HAc:ACN, + NH4HCO2 + 4.0 mL of ascorbic acid 0.02 M in HCl 0.24 M + 5 g Na2SO4. The mixture was centrifuged and cleaned with C18-MgSO4 and diluted to 500 | QuEChERS | HPLC-MS/MS | 0.4–1.5 | 78.1–97.1% | [ |
|
| |||||||
| QNs | Honey | 1 g sample + 30 mM NaH2PO4 buffer pH 7.0 + 5% formic acid in ACN | — | UHPLC-MS/S | 0.2–4.1 | 70.1–93.7% | [ |
|
| |||||||
| SAs | Chicken muscle and eggs | 5 g sample + 5.0 mL water + 10.0 mL ACN: 1% HAc was shaken and 4 g MgSO4 + 1 g NaOAc shaken and centrifuged | QuEChERS/PSA/QuE Z-Sep+ | HPLC-FLD | 4.66–28.33 | 65.9–88.1% | [ |
|
| |||||||
|
| Meat | 5 g sample + 4.0 mL of 0.05 M acetate pH 5.2 + 50 | QuEChERS | LC-MS/MS | 0.2–0.9 | 65.0–100.0% | [ |
ACN: acetonitrile; BAs: benzimidazole anthelmintics; BZDs: benzimidazoles; CAP: chloramphenicol; CBZ: carbendazim; CE: capillary electrophoresis; DAD: diode-array detection; DSPE: dispersive solid-phase extraction; DMSO: dimethyl sulfoxide; DVB-NVP: divinylbenzene/N-vinylpyrrolidone copolymer; ESI-MS/MS: electrospray ionization tandem mass spectrometry (ESI-MS/MS); EMR-L: enhanced matrix removal for lipids; HPLC: high performance liquid chromatography; FL: fluorescence; FF: florfenicol; LC: liquid chromatography; MeOH: methanol; MgSO4: magnesium sulfate; MS: mass spectrometry; NaCl: sodium chloride; Na2EDTA: ethylenediaminetetraacetic acid disodium salt; NSAIDs: nonsteroidal anti-inflammatory drugs; PSA: primary and secondary amine; QNs: quinolones; SAs: sulfonamide; TAP: thiamphenicol; UHPLC: ultra-high performance liquid chromatography; UV: ultraviolet detection.